{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:00:26Z","timestamp":1761393626852,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.clinph.2019.07.029","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T11:57:56Z","timestamp":1565956676000},"page":"1988-1994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy\/dy mouse model by glatiramer acetate"],"prefix":"10.1016","volume":"130","author":[{"given":"Malcolm","family":"Rabie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurit","family":"Yanay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakov","family":"Fellig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenya","family":"Konikov-Rozenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Nevo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2019.07.029_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12016-010-8246-7","article-title":"The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally","volume":"42","author":"Aronovich","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clinph.2019.07.029_b0010","doi-asserted-by":"crossref","first-page":"14593","DOI":"10.1073\/pnas.0404887101","article-title":"Mechanism of action of Glatiramer acetate in multiple sclerosis and its potential for the development of new applications","volume":"101","author":"Arnon","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.clinph.2019.07.029_b0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00005072-197709000-00003","article-title":"The nodes of Ranvier in the nerves of mice with muscular dystrophy","volume":"36","author":"Bradley","year":"1977","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.clinph.2019.07.029_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11910-010-0092-8","article-title":"Congenital muscular dystrophies: toward molecular therapeutic interventions","volume":"10","author":"Collins","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.clinph.2019.07.029_b0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0960-8966(01)00232-2","article-title":"Three mouse models of muscular dystrophy: the natural history of strength and Fatigue in dystrophin-, dystrophin\/utrophin-, and laminin alpha2-deficient mice","volume":"11","author":"Connolly","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clinph.2019.07.029_b0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nmd.2010.02.002","article-title":"Improved muscle strength and mobility in the dy(2J)\/dy(2J) mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate","volume":"20","author":"Dadush","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clinph.2019.07.029_b0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.10326","article-title":"Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy","volume":"27","author":"Di Muzio","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.07.029_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13395-015-0055-5","article-title":"Mesoangioblast delivery of miniagrin ameliorates murine model of merosin deficient congenital muscular dystrophy type 1A","volume":"5","author":"Domi","year":"2015","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.clinph.2019.07.029_b0045","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1523\/JNEUROSCI.0523-07.2007","article-title":"Repair capacity for platinum-DNA adducts determines the severity of cisplatin- induced peripheral neuropathy","volume":"27","author":"Dzagnidze","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinph.2019.07.029_b0050","doi-asserted-by":"crossref","first-page":"e1690","DOI":"10.1038\/cddis.2015.60","article-title":"Life or death by NF\u03baB, Losartan promotes survival in dy2J\/dy2J mouse of MDC1A","volume":"6","author":"Elbaz","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clinph.2019.07.029_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2044-5040-1-9","article-title":"Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies","volume":"1","author":"Gawlik","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.clinph.2019.07.029_b0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/MCB.06270-11","article-title":"Developmental regulation of microRNA expression in Schwann Cells","volume":"32","author":"Gokey","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clinph.2019.07.029_b0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-510X(72)90067-6","article-title":"Myelinated nerve fibre counts in the nerves of normal and dystrophic mouse muscle","volume":"15","author":"Harris","year":"1972","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinph.2019.07.029_b0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng1095-216","article-title":"Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin- deficient congenital muscular dystrophy","volume":"11","author":"Helbling-Leclerc","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinph.2019.07.029_b0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1113\/jphysiol.1975.sp010971","article-title":"Electrophysiological properties of spinal motoneurones of normal and dystrophic mice","volume":"248","author":"Huizar","year":"1975","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2019.07.029_b0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(83)91141-1","article-title":"Quantitative studies of the abnormal axon-Schwann cell relationship in the peripheral motor and sensory nerves of the dystrophic mouse","volume":"258","author":"Jaros","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.clinph.2019.07.029_b0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00018-004-4510-4","article-title":"Congenital muscular dystrophy: molecular and cellular aspects","volume":"62","author":"Jimenez-Mallebrera","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clinph.2019.07.029_b0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/11588120-000000000-00000","article-title":"Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action","volume":"25","author":"Lalive","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinph.2019.07.029_b0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/257319a0","article-title":"Genetically determined defect of Schwann cell basement membrane in dystrophic mice","volume":"257","author":"Madrid","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.clinph.2019.07.029_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0960-8966(96)00402-6","article-title":"Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse","volume":"7","author":"Matsumura","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clinph.2019.07.029_b0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-510X(78)90247-2","article-title":"Further observations on myelinated axon numbers in normal and dystrophic mice","volume":"38","author":"Montgomery","year":"1978","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinph.2019.07.029_b0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2004.06.009","article-title":"The congenital muscular dystrophies in 2004: a century of exciting progress","volume":"14","author":"Muntoni","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clinph.2019.07.029_b0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/glia.1075","article-title":"Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K\/dy3K) mice","volume":"35","author":"Nakagawa","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.clinph.2019.07.029_b0120","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.2068-05.2005","article-title":"Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier","volume":"25","author":"Occhi","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinph.2019.07.029_b0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2010.07.076","article-title":"The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6\/J mice","volume":"483","author":"Oh","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clinph.2019.07.029_b0130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mus.21284","article-title":"Noninvasive model of sciatic nerve conduction in healthy and septic mice: reliability and normative data","volume":"40","author":"Osuchowski","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2019.07.029_b0135","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1242\/jcs.015354","article-title":"A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination","volume":"121","author":"Patton","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.clinph.2019.07.029_b0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-8993(78)90753-9","article-title":"Conduction of nervous impulses in spinal roots and peripheral nerves of dystrophic mice","volume":"143","author":"Rasminsky","year":"1978","journal-title":"Brain Res"},{"key":"10.1016\/j.clinph.2019.07.029_b0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.clinph.2019.07.029_b0150","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/088307389501000610","article-title":"Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy","volume":"10","author":"Shorer","year":"1995","journal-title":"J Child Neurol"},{"key":"10.1016\/j.clinph.2019.07.029_b0155","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0006-8993(75)90794-5","article-title":"Experimentally induced myelination of amyelinated axons in dystrophic mice","volume":"87","author":"Stirling","year":"1975","journal-title":"Brain Res"},{"key":"10.1016\/j.clinph.2019.07.029_b0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138945008783431763","article-title":"Criteria for creating and assessing mouse models of diabetic neuropathy","volume":"9","author":"Sullivan","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.clinph.2019.07.029_b0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0960-8966(96)00421-X","article-title":"Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency","volume":"7","author":"Tan","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clinph.2019.07.029_b0175","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/glia.20846","article-title":"Peripheral Myelin protein 22 is regulated post-transcriptionally by miRNA-29a","volume":"57","author":"Verrier","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.clinph.2019.07.029_b0180","doi-asserted-by":"crossref","first-page":"e24604","DOI":"10.1371\/journal.pone.0024604","article-title":"Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis","volume":"6","author":"Waschbisch","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinph.2019.07.029_b0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.200411158","article-title":"Coordinate control of axon defasciculation and myelination by laminin-2 and -8","volume":"168","author":"Yang","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.clinph.2019.07.029_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2202-10-77","article-title":"Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy","volume":"10","author":"Yoon","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.clinph.2019.07.029_b0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/icb.2013.81","article-title":"Glatiramer acetate ameliorates experimental autoimmune neuritis","volume":"92","author":"Zhang","year":"2014","journal-title":"Immunol Cell Biol"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245719311848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245719311848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:55:34Z","timestamp":1761393334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245719311848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1388245719311848"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2019.07.029","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy2J\/dy2J mouse model by glatiramer acetate","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2019.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.","name":"copyright","label":"Copyright"}]}}